Author

C. Riether

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

V. Rubino· 2 shared A. F. Ochsenbein· 1 shared A. J. Macpherson· 1 shared A. Ochsenbein· 1 shared C. Mooser· 1 shared E. Szegezdi· 1 shared F. Ronchi· 1 shared H. Alizadeh Zeinabad· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

V. Rubino

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Low abundant intestinal commensals modulate immune control of chronic myeloid leukemia stem cells

M. Hinterbrandner, F. Ronchi, V. Rubino, M. Roemmele, T. Chiorazzo, C. Mooser, S. C. Ganal-Vonarburg, K. D. McCoy, A. J. Macpherson, A. F. Ochsenbein, C. Riether

This study identifies Sutterella wadsworthensis as a low-abundant intestinal commensal that suppresses anti-leukemia immune responses in chronic myeloid leukemia.

bioRxiv · May 31, 2024 · PreprintCancer Biology

CD4+ T cell-derived IL21 regulates stem cell fate in acute myeloid leukemia by activation of p38-MAPK signaling

V. Rubino, M. Hueppi, S. Hoepner, L. Tortola, L. Taylor, I. Keller, R. Bruggmann, M.-N. Kronig, U. V. Bacher, M. Kopf, A. Ochsenbein, C. Riether

This study identifies IL21 from CD4+ T cells as a negative regulator of leukemia stem cell self-renewal through ROS and p38-MAPK signaling, with prognostic implications in AML.

bioRxiv · Sep 1, 2023 · PreprintCancer Biology

Natural killer cell-mimic nanoparticles can actively target and kill acute myeloid leukemia cells

H. Alizadeh Zeinabad, W. J. Yeoh, M. Lomora, Y. Banz, C. Riether, P. Krebs, E. Szegezdi

This study develops NK cell-mimic nanoparticles that target and kill AML cells by combining TRAIL cytotoxicity and CD16-based antibody recognition.

bioRxiv · Sep 9, 2022Cancer Biology